A novel approach to the treatment of chronic allograft nephropathy

Transplantation

Volumn 64, Issue 12, 1997, Pages 1706-1710

  Weir, Matthew R ^a,b   Anderson, Leslie ^c   Fink, Jeffrey C ^a   Gabregiorgish, Kennedy ^a   Schweitzer, Eugene J ^c   Hoehn Saric, Edward ^a   Klassen, David K ^a   Cangro, Charles B ^a   Johnson, Lynt B ^c   Kuo, Paul C ^c   Lim, James Y ^c   Bartlett, Stephen T ^c  

^a Division of Transplantation   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; CADAVER; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; PROSPECTIVE STUDIES;

EID: 0031449010     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00013     Document Type: Conference Paper

References (34)

1. Gjertson DW. Survival trends in long-term first cadaver-donor kidney transplants. In: Terasaki P, ed. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 225.
2. Schweitzer EJ, Matas AJ, Gillingham K. Causes of renal allograft loss: progress in the '80s, challenges for the '90s. Ann Surg 1991; 214: 679.
3. Chavers BM, Kim EM, Matas AJ, et al. Causes of kidney allograft loss in a large pediatric population at a single center. Pediatr Nephrol 1994; 8: 57.
4. Foster NC, Morgan AG, Rowe PA, et al. Characteristics of cadaveric renal allograft recipients developing chronic rejection. Ann R Coll Surg 1990; 72: 23.
5. Tilney NL, Whitley WD, Diamond JR, et al. Chronic rejection: an undefined conundrum. Transplantation 1991; 52: 389.
6. Almond PS, Matas AJ, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
7. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
8. Hayry P, Mennander A, Ruisanen, et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev 1993; 7: 1.
9. Reinsmoen NL, Matas AJ. Improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporesponsiveness. Transplantation 1993; 55: 1017.
10. Gjertson DW. Short- and long-term effects of HLA matching. In: Terasaki P, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1989: 353.
11. Opelz G, Schwarz V, Engelmann A, Back D, Wilk M, Keppel E. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients. Transplant Proc 1991; 23: 373.
12. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53: 55.
13. Matas AJ, Burke JF Jr, DeVault GA Jr, Monaco A, Pirsch JD. Chronic rejection. J Am Soc Nephrol 1994; 4: S23.
14. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85.
15. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of glomerular disease. Kidney Int 1983; 23: 647.
16. Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989; 13: 443.
17. Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21: 66.
18. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy in renal transplantation. Transplant Proc 1996; 28: 2100.
19. Vanrenterghem Y, Peeters J, for the Leuven Collaborative Group for Transplantation. Chronic renal allograft function under cyclosporin treatment. Transplant Proc 1996; 28: 2097.
20. European MMF Cooperative Study Group. Placebo-controlled study of MMF combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321.
21. Sollinger HW, for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
22. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148.
23. Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1994; 58: 1317.
24. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
25. Gulanikar AC, MacDonald AS, Sungurtein U, Belitsky P. The incidence and impact of early rejection episodes of graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
26. Ferguson RM, Henry M, Elkhammas EA, Tesi RJ. Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival [Abstract]. American Society of Transplant Surgeons, 18th Annual Scientific Meeting, Chicago, IL, 1992.
27. Matas AJ, Gillingham K, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
28. Wrenshall LE, Matas AJ, Canafax DM, et al. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 1990; 50: 233.
29. Van Buren DH, Burke JF, Lewis RM. Renal function in patients receiving long-term cyclosporine therapy. J Am Soc Nephrol 1994; 4: S17.
30. Sanfillipo F. Renal transplantation. In: Sale GE, ed. The pathology of organ transplantation. Boston: Butterworths, 1990: 51.
31. Almond PS, Gillingham KJ, Sibley R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316.
32. Schurter G, Glicklich D, Greenstein SM, et al. Mycophenolate mofetil therapy for chronic rejection in renal transplant recipients. Am Soc Transplant Physicians Abstract Book 1997; 16: 133 (196A).
33. Smith MT, Newby BS, Rao RN, Mulloy LL, Humphries AL, Wynn JJ. Response to MMF in patients with chronic renal allograft rejection. Am Soc Transplant Physicians Abstract Book 1997; 16: 134 (197A).
34. Khanna A, Baogui L, Stenzel KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth. Transplantation 1994; 57: 577.